In responders , patients showing sustained UA lowering , mean anti-pegloticase titers at week 25 ( 1:837 1687 with biweekly and 1:2025 4506 with monthly dosing ) were markedly lower than in nonresponders ( 1:34,528 42,228 and 1:89,658 297,797 , respectively ) .